CClinicalTrials.gg
Status unknownNCT03205878Updated Jul 2, 2017

Telecoaching to Improve Physical Activity in Patients With Obstructive Sleep Apnea

An interventional study of Telecoaching and CPAP in Physical Activity and Obstructive Sleep Apnea, sponsored by Universitaire Ziekenhuizen KU Leuven. Status unknown. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-07-02.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Patients with obstructive sleep apnea (OSA) are less physically active than healthy controls.

First choice of treatment for OSA is continuous positive airway pressure (CPAP) therapy with an improvement in oxygen saturation and sleep. No improvement on physical activity has been shown.

The current study would randomize patients in a standard care group (CPAP) and an intervention group (CPAP + telecoaching). Telecoaching will be performed for 3 months, with physical activity assessment before, after 3 months and 12 years.

02

Conditions studied

  • Physical Activity
  • Obstructive Sleep Apnea
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

This study's planned enrollment of 102 is above the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 928 studies on the registry; 261 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • AHI > 15 events/hour, measured by polysomnography
  • \< 7,500 steps per day
  • Willing to start CPAP treatment
  • Age between 18 and 65 years
  • Signing the written informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients with neuromuscular diseases
  • Patients with chronic obstructive pulmonary disease and interstitial lung disease
  • Patients with cardiac failure and ischemic heart failure
  • Patients with comorbidities which could interfere with a normal biomechanical gait pattern and the possibility of increasing physical activity
  • Patients with mental disability making it impossible to understand the study protocol and the use of electronic devices.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (estimated)

Study arms

  • Active comparator
    Control group

    Patients will receive standard care, being CPAP treatment

    Device: CPAP

  • Experimental
    Intervention group

    Patients will receive CPAP and telecoaching

    Other: Telecoaching · Device: CPAP

Interventions

  • OtherTelecoaching

    Patients in the intervention arm will receive a step counter and a cell phone with an app on which the amount of steps are daily sent to. Initial targets on steps per day will be discussed with the patient after an activity monitoring before the telecoaching procedure. Dependent whether the patient reaches his/her proposed goal each week, new goals are set.

  • DeviceCPAP

    Patients will receive CPAP according to standard care

06

What researchers measure

Primary outcomes

  1. Change in steps per day after 3 months

    Steps per day as measured by a step counter

    Time frame: The change will be measured after 3 months

Secondary outcomes

  1. The proportion of patients with an increase > 1,000 steps per day

    Time frame: After 3 months (end of telecoaching) and after 12 months

  2. The proportion of patients with > 7500 steps/day

    Time frame: Before initiation of telecoaching (baseline), after 3 months (end of telecoaching) and after 12 months

  3. Change in functional exercise capacity

    6-minute walking distance

    Time frame: 3 months and 12 months compared with baseline

  4. Change in daytime sleepiness

    Epworth Sleepiness Scale

    Time frame: 3 months and 12 months compared with baseline

  5. Change in sleep quality

    Pittsburgh Sleep Quality Index

    Time frame: 3 months and 12 months compared with baseline

  6. Change in endothelial function

    Endo-PAT 2000 measurement

    Time frame: 3 months and 12 months compared with baseline

  7. Change in body composition

    Bodystat 1500 measurement

    Time frame: 3 months and 12 months compared with baseline

  8. Change in quality of life

    SF-36 questionnaire

    Time frame: 3 months and 12 months compared with baseline

  9. Change in steps per day after 12 months

    Steps per day as measured by a step counter

    Time frame: The change will be measured after 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03205878
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Responsible party
Sponsor
First posted
Jul 2, 2017
Start date
Jul 1, 2017 (estimated)
Primary completion
Dec 31, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Jul 2, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion